Supreme Petrochem
- P/E
- 27.10
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 18.80%
- Debt to Equity
- 0.05
- EPS (TTM)
- ₹25.67
- Book Value
- ₹135.77
- Market Cap
- —
- P/E (TTM)
- 27.10
- P/B
- 5.12
- ROE
- 14.10%
- Dividend Yield
- 0.36%
- EBITDA
- ₹565 Cr
- 52W High
- ₹899.00
- 52W Low
- ₹462.30
- Day Range
- ₹689.00 – ₹705.00
- Volume
- 89,966
Peer Comparison
Commodities › Chemicals › Petrochemicals
| ₹695.70 | 27.10 | ₹13,137 Cr | 5.12 | 0.36% | 14.10% | 18.80% | ₹5,645 Cr | ₹482 Cr | |
| ₹244.59 | — | ₹7,604 Cr | 1.07 | 0.06% | −4.50% | −0.58% | ₹4,172 Cr | ₹208 Cr | |
| ₹183.97 | 11.52 | ₹6,028 Cr | 0.77 | 0.55% | 0.60% | 8.26% | ₹18,464 Cr | ₹667 Cr | |
| ₹110.26 | 13.71 | ₹2,612 Cr | 2.36 | 1.89% | 17.30% | 23.80% | ₹1,440 Cr | ₹200 Cr | |
| ₹46.31 | 19.14 | ₹1,330 Cr | 1.22 | 0.66% | 4.74% | 9.89% | ₹2,210 Cr | ₹72 Cr | |
| ₹72.96 | 6.97 | ₹1,221 Cr | 0.98 | 0.71% | 4.38% | 7.25% | ₹1,062 Cr | ₹179 Cr | |
| ₹119.77 | 7.57 | ₹1,091 Cr | 0.94 | 1.26% | 9.20% | 10.90% | ₹1,783 Cr | ₹142 Cr | |
| Median 7 companies | ₹119.77 | 12.62 | ₹2,612 Cr | 1.07 | 0.66% | 4.74% | 9.89% | ₹2,210 Cr | ₹200 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 62
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 41
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 13
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 85
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 40
- Weak
- Trend strength, vol-adjusted 12% weight
- Ownership
- 56
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 52.4%
Weaknesses
1- The company has delivered a poor sales growth of 10.9% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 35.20
- Neutral
- MACD (12,26,9)
- −26.75
- Bearish
- SMA (50)
- 771.86
- Bearish
- SMA (200)
- 710.29
- Bearish
As of
Analyst Rating
1 of 1 analyst rates Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | Irregular period |
|---|---|
| 5Y | +10.88% |
| 3Y | +0.32% |
| 1Y | −11.37% |
| TTM | −3.29% |
Net profit
| 10Y | Irregular period |
|---|---|
| 5Y | −7.27% |
| 3Y | −13.08% |
| 1Y | −16.37% |
| TTM | +38.11% |
Operating cash flow
| 10Y | Irregular period |
|---|---|
| 5Y | −10.77% |
| 3Y | −6.81% |
| 1Y | −28.07% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | Irregular period |
|---|---|
| 5Y | −11.44 pp |
| 3Y | −2.78 pp |
| 1Y | +0.84 pp |
| TTM | +4.66 pp |
Revenue by year
| Mar 2017 | ₹2,919 Cr |
|---|---|
| Mar 2018 | ₹3,027 Cr |
| Mar 2019 | ₹3,194 Cr |
| Mar 2020 | ₹2,724 Cr |
| Mar 2021 | ₹3,185 Cr |
| Mar 2022 | ₹5,032 Cr |
| Mar 2023 | ₹5,287 Cr |
| Mar 2024 | ₹5,253 Cr |
| Mar 2025 | ₹6,023 Cr |
| Mar 2026 | ₹5,338 Cr |
Net profit by year
| Mar 2017 | ₹179 Cr |
|---|---|
| Mar 2018 | ₹116 Cr |
| Mar 2019 | ₹49.00 Cr |
| Mar 2020 | ₹103 Cr |
| Mar 2021 | ₹477 Cr |
| Mar 2022 | ₹663 Cr |
| Mar 2023 | ₹498 Cr |
| Mar 2024 | ₹346 Cr |
| Mar 2025 | ₹391 Cr |
| Mar 2026 | ₹327 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Supreme Petrochem Ltd trades at ₹725.2 as of 2026-10-28 with a market cap of ₹13,637 Cr. The company is virtually debt-free (debt-to-equity of 0.05) and has delivered a TTM profit growth of 40%, but faces tepid revenue momentum with TTM sales growth of -3% and a 3-year compounded sales CAGR of 0%.
- Near-zero leverage with a debt-to-equity ratio of just 0.05, providing significant financial flexibility and balance sheet resilience in a cyclical chemicals sector.
- TTM compounded profit growth of 40% indicates a sharp recovery in margins and earnings power despite weak top-line trends.
- Healthy dividend payout ratio of 52.4% signals shareholder-friendly capital allocation, supported by the current dividend yield of 0.35%.
- Long-term wealth creation track record with a 10-year stock CAGR of 20% and 10-year compounded profit growth of 19%.
- ROCE of 18.13% reflects efficient capital deployment and solid return generation on invested capital.
- Stock is trading 19.3% below its 52-week high of ₹899, having recovered significantly from the 52-week low of ₹462.3 — a 56.9% rebound from the bottom.
- 5-year compounded sales CAGR of 11% and 10-year sales CAGR of 10% demonstrate a reasonable long-term revenue trajectory despite recent softness.
- TTM revenue growth is negative at -3%, and the 3-year compounded sales CAGR is flat at 0%, pointing to persistent top-line stagnation.
- PE ratio of 28.25x is elevated for a chemicals company with flat-to-negative recent sales growth, suggesting the stock prices in significant future improvement.
- ROE has declined from a 5-year average of 23% and 10-year average of 24% down to 13.88% (last year 14%), indicating deteriorating return on equity.
- 3-year compounded profit CAGR of -12% and 5-year profit CAGR of -7% show that the TTM profit spike has not yet reversed a multi-year earnings decline.
- 1-year stock CAGR of -5% shows the market has recently de-rated the stock despite the TTM profit recovery.
- Cyclical chemicals sector exposure means the 40% TTM profit jump could reverse if commodity spreads or demand conditions deteriorate.
- Dividend yield of just 0.35% offers limited income cushion relative to prevailing risk-free rates in India.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Supreme Petrochem is delivering exceptional operational performance with Q2 profit nearly doubling and H1 PAT up 156.6%, supported by strong revenue growth across segments. The key risk is that the stock remains 27% below its record high and has seen post-results selling pressure despite the blowout numbers. The dividend declaration signals management confidence in cash flows. The underlying business trend is clearly improving, but broader market sentiment and valuation recovery remain the near-term overhang to watch.
- Stock down 27% from record high Oct 23
Shares have fallen 27% from the record high of ₹979 to around ₹712, and ended the session at ₹710.10, down 3.87% on the BSE despite strong Q2 results.
- Share price volatility in 2026 Oct 23
Stock has swung between gains and losses amid weak broader-market sentiment, and declined marginally by 2% in 2025 after five consecutive years of positive returns.
- Q2 profit nearly doubles YoY Oct 23
Net profit surged 97.9% YoY to ₹95 crore in Q2 FY27, with revenue jumping 77.8% to ₹1,956 crore and operational EBITDA up 91.4% to ₹148.5 crore.
- H1 FY27 PAT up 156.6% Oct 23
First-half PAT climbed 156.6% to ₹331.3 crore from ₹129.1 crore, with H1 revenue growing 46.8% to ₹3,649.4 crore and operational EBITDA surging 149.1% to ₹479.1 crore.
- Interim dividend of ₹2.50/share Oct 23
Board declared a first interim dividend of ₹2.50 per share (125% of face value) for FY27, totalling ₹47.01 crore outgo, with October 30 as the record date.
- T+1 settlement dividend cutoff Oct 23
Under India's T+1 settlement cycle, investors must purchase shares before the October 30 record date to qualify for the ₹2.50 interim dividend payout.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 | 1,100 | 1,265 | 1,587 | 1,693 | 1,957 |
| Expenses | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 | 1,023 | 1,195 | 1,334 | 1,362 | 1,808 |
| Operating Profit | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 | 78 | 69 | 253 | 331 | — |
| OPM % | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% | 7% | 5% | 16% | 20% | — |
| Other Income | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 | 9 | 2 | 8 | 17 | 11 |
| Interest | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 |
| Depreciation | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 | 18 | 27 | 28 | 28 | 28 |
| PBT | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 | 65 | 40 | 229 | 317 | 128 |
| Tax % | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 27% | 25% | 26% |
| Net Profit | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 | 48 | 30 | 168 | 236 | 95 |
| EPS (₹) | 3.68 | 4.15 | 3.6 | 6.99 | 6.49 | 4.8 | 3.79 | 5.68 | 4.3 | 2.56 | 1.6 | 8.94 | 12.57 | — |
Sep 2026: from the results filed on 23 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Jun 2015 | Mar 2016 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,338 | 5,645 |
| Expenses | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 4,820 | 4,914 |
| Operating Profit | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 519 | 731 |
| OPM % | 3.5% | 5% | 10% | 6% | 2.9% | 5% | 21% | 18% | 12% | 9% | 9% | 10% | 13% |
| Other Income | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 33 | 36 |
| Interest | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 17 | 14 |
| Depreciation | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 91 | 101 |
| PBT | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 443 | 651 |
| Tax % | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | 26% | — |
| Net Profit | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 327 | 483 |
| EPS (₹) | 1.85 | 2.96 | 9.3 | 6.02 | 2.55 | 5.32 | 25.4 | 35.28 | 26.49 | 18.43 | 20.77 | 17.41 | 25.67 |
| Div. Payout % | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% | 60% | — |
Balance Sheet
₹ Cr| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,333 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 126 |
| Other Liabilities | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 970 |
| Total Liabilities | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
| Fixed Assets | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,474 |
| CWIP | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 74 |
| Investments | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 324 |
| Other Assets | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,594 |
| Total Assets | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
Cash Flow
₹ Cr| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 80 | 84 | 69 | 213 | 133 | 120 | 435 | 672 | 304 | 557 | 342 | 246 |
| Investing | −5 | −5 | −25 | −15 | −27 | −8 | −64 | −140 | −147 | −182 | −330 | −190 |
| Financing | −66 | −40 | −16 | −57 | −56 | −90 | −104 | −178 | −194 | −197 | −212 | −228 |
| Net Cash Flow | 9 | 39 | 27 | 141 | 50 | 22 | 266 | 354 | −37 | 178 | −201 | −171 |
| Free Cash Flow | 73 | 77 | 41 | 194 | 101 | 104 | 413 | 509 | 98 | 245 | −36 | 37 |
| CFO/EBITDA | 96 | 117 | 53 | 140 | 167 | 107 | 89 | 99 | 72 | 140 | 87 | 67 |
Ratios
| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 | 34 |
| Inventory Days | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 | 51 |
| Days Payable | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 | 65 |
| Cash Conversion Cycle | 1 | 3 | 19 | 0 | 3 | 0 | 4 | 8 | 14 | 0 | 8 | 20 |
| Working Capital Days | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 | 15 |
| ROCE % | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Supreme Petrochem insights
65 extracted metrics across FY11–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · Apr 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT
- Q2 FY26 concall · Oct 2025Transcript PPT Recording
- 27 Feb 2026
- 13 Dec 2024
- 4 Oct 2024
- 25 Sep 2023
- 7 Sep 2023
Frequently Asked Questions about Supreme Petrochem
What does Supreme Petrochem Ltd do?
Where is Supreme Petrochem Ltd (SPLPETRO) listed?
Which sector does Supreme Petrochem Ltd belong to?
What is the PE ratio of Supreme Petrochem Ltd?
What is the 52-week high and low of Supreme Petrochem Ltd?
Does Supreme Petrochem Ltd pay dividends?
What is the Return on Equity (ROE) of Supreme Petrochem Ltd?
Company Information
Supreme Petrochem Ltd (SPL) is a petrochemical company engaged in the business of manufacturing Polystyrene, Compounds of Styrenics and other Polymers.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SPLPETRO.md for Supreme Petrochem Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.